Twenty-four patients were stratified as G2019S LRRK2 mutation carriers (LRRK2-PD) and thirty-nine as idiopathic PD subjects without the G2019S LRRK2 or GBA mutations (iPD). This evidence concerns the gene LRRK2 and Parkinson disease.